Authors

Intracranial activity of ifinatamab deruxtecan (I-DXd) in patients with extensive-stage small cell lung cancer and baseline brain metastases: Primary analysis of IDeate-Lung01

Scientists Create Nanoparticle That Helps Fight Solid Tumors

Dr Choi on the Importance of Education on CAR T-Cell Therapy Manufacturing in Hematologic Malignancies

Dr. Maziéres on the Evaluation of Tepotinib Plus Osimertinib in EGFR-mutated NSCLC

Dr Mohan on CAR T-cell Therapies and Bispecific Antibodies in R/R Multiple Myeloma

Belantamab Mafodotin, Bortezomib, and Dexamethasone Vs Daratumumab, Bortezomib, and Dexamethasone in Relapsed/Refractory Multiple Myeloma: Overall Survival Analysis and Updated Efficacy Outcomes of the Phase 3 Dreamm-7 Trial

Dr Kurz on the Efficacy and Safety of Lutetium Lu 177 Dotatate in Advanced Intracranial Meningioma

Dr Chambers on the Importance of Patient Counseling in Ovarian Cancer

Sequencing of Systemic NETS Treatments

Dr Samarasinghe on the Feasibility of First-Line Blinatumomab in Down Syndrome B-ALL

Responding to Resistance in Lung Cancer

Dr. Garutti on the Potential Shift to Neoadjuvant Therapy in Melanoma

Review of the SELECT-AML-1 Trial and the Future of Newly Diagnosed AML

Managing Immunotoxicities With CAR T-Cell Therapy for B-ALL

Dr. Azad on the Significance of the PROfound Trial in mCRPC

Dr. Farrington on the Importance of Genetic Testing in CRC

Metastasis Patterns of Basal Cell Carcinoma

Dr Nagpal on the FDA Approval of Vorasidenib for Grade 2 Astrocytoma or Oligodendroglioma